Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
491 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019
492 Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study Department of Pathology Amira Emad Mohamed Elwy 2019
493 Immunohistochemical study of folate receptor-α and mammalian
target of rapamycin in endometrial hyperplasia and
endometrioid endometrial carcinoma


 		Department of Radiotherapy and Nuclear medicine Dr. Asmaa elsayed abdelsalam /hasaballah 2019
494 Assesment OF complement regulatory protients CD55 and CD59 on erythocytes in Betathalassemia major patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2019
495 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) Department of Medical Oncology Dr. Abeer Elsayed Ali Ibrahim 2019
496 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Nehal Adel Rayan Mohammed 2019
497 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019
498 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2019
499 Long-Term Evaluation of Imatinib´s Effect on Bone
Marrow Fibrosis in Patients with Chronic Myeloid
Leukemia 		Department of Medical Oncology Dr. Adel Gomaa Mohamed Gabr 2019
500 Long-Term Evaluation of Imatinib´s Effect on Bone
Marrow Fibrosis in Patients with Chronic Myeloid
Leukemia 		Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019